[Federal Register Volume 78, Number 78 (Tuesday, April 23, 2013)]
[Notices]
[Pages 23959-23960]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-09530]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Cayman Chemical Company
By Notice dated November 14, 2012, and published in the Federal
Register on November 23, 2012, 77 FR 70188, Cayman Chemical Company,
1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application
to the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
[[Page 23960]]
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
JWH-250 (6250)............................. I
SR-18 also known as RCS-8 (7008)........... I
JWH-019 (7019)............................. I
JWH-081 (7081)............................. I
SR-19 also known as RCS-4 (7104)........... I
JWH-122 (7122)............................. I
AM-2201 (7201)............................. I
JWH-203 (7203)............................. I
2C-T-2 (7385).............................. I
JWH-398 (7398)............................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
2C-D (7508)................................ I
2C-E (7509)................................ I
2C-H (7517)................................ I
2C-I (7518)................................ I
2C-C (7519)................................ I
2C-N (7521)................................ I
2C-P (7524)................................ I
2C-T-4 (7532).............................. I
AM-694 (7694).............................. I
Phenylacetone (8501)....................... I
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
for distribution to their research and forensic customers conducting
drug testing and analysis.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cayman Chemical Company to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cayman Chemical Company to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: April 16, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-09530 Filed 4-22-13; 8:45 am]
BILLING CODE 4410-09-P